Facilities

Audentes invests in large-scale gene therapy manufacture

19-Feb-2020 By Ben Hargreaves

Audentes augments its in-house production capacity with additional plans for a North Carolina facility.

Catalent takes over Zumutor’s lead candidate manufacture

13-Feb-2020 By Vassia Barba

Under an agreement with Zumutor, Catalent Biologics initiates clinical manufacture of the latter’s lead candidate targeting solid tumors, ahead of FDA filing.

Novo Nordisk continues ‘investment year’ with expansion of production

12-Feb-2020 By Ben Hargreaves

The company announces the injection of DKK 800m into the Kalundborg facilities responsible for producing its diabetes treatments.

Biogen prepares to step up manufacturing to support Alzheimer's launch

12-Feb-2020 By Nick Taylor

Biogen readies manufacturing operation to meet anticipated “large demand” for Alzheimer’s disease drug.

GSK separation leads to 935 jobs cuts from vaccine business

11-Feb-2020 By Vassia Barba

GSK announces plans to separate out its consumer health business and cut 935 roles from its vaccines business in Belgium.

Amgen looks to biologics manufacturing tech to cut carbon emissions

11-Feb-2020 By Nick Taylor

Amgen commits to next-generation biologics manufacturing technologies in attempt to reduce environmental impact.

Consolidation continues as Catalent lays down $330m for MaSTherCell

05-Feb-2020 By Ben Hargreaves

Catalent provides another example of the trend by bigger CDMO to snatch up smaller cell and gene therapy specialists.

Takeda set to divest $400m Irish facility

04-Feb-2020 By Ben Hargreaves

The facility was completed prior to Takeda’s acquisition of Shire and is now deemed surplus to requirements.

WuXi Biologics advises clients against China travel during Wuhan outbreak

03-Feb-2020 By Nick Taylor

Chinese CDMO WuXi Biologics advises clients against travelling for face-to-face meeting during the Wuhan outbreak.

Merck builds €250m biotech R&D facility in Switzerland

30-Jan-2020 By Vassia Barba

Merck to build a Biotech Development Center that will deliver clinical trial material for its R&D pipeline.

Kamada raises $25M to pick up products to fill manufacturing facility

30-Jan-2020 By Nick Taylor

Kamada sells shares to private equity group to support push to fill capacity at plasma production site.

Bellicum offloads cell therapy plant in switch to outsourced production

28-Jan-2020 By Nick Taylor

Bellicum sells cell therapy manufacturing plant to MD Anderson Cancer Center, strikes master service agreement.

Krystal Biotech continues internal buildout with second facility

28-Jan-2020 By Ben Hargreaves

The gene therapy company breaks ground on a backup facility ahead of the potential commercial launch of its lead therapy, B-VEC.

New CDMO plans $1.1bn cell and gene therapy plant

27-Jan-2020 By Nick Taylor

A newly founded CDMO has outlined plans to invest $1.1bn to become the world’s biggest cell and gene therapy service provider.

Large pharma focusing on in-house biologic manufacture, not outsourcing

24-Jan-2020 By Ben Hargreaves

Capital expenditure is rising across the pharma industry as portfolios and pipelines shift towards biologics, but the largest companies are sticking to in-house production.

Product Innovations

Survey Report: State of the global biomanufacturing and bioprocessing industry 2017

In September 2017, BioPharma-Reporter.com conducted its second annual ‘state of the industry’ survey on its user base of biopharmaceutical industry professionals....

Survey Report: State of the Biopharmaceutical Industry 2016

In May 2016, BioPharma-Reporter conducted its inaugural ‘state of the industry’ survey. The key objective of the poll was to gauge views about the current...